Treatment
Medication clinical trials
We’re tracking 7,451 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06700187Recruiting
Does reducing sitting time improve thinking?
This study looks at whether taking short breaks from sitting can help your brain work better. You will visit a lab 4 times and will be asked to sit or take short breaks while your thinking is tested.
MaastrichtAges 18–35 - NCT06702072Recruiting
Oxygen use after lung valve treatment
Researchers want to see if a bronchoscopic lung volume reduction procedure with Zephyr valves changes how much oxygen your body uses during simple tasks. You may be eligible if you are scheduled for this valve treatment and do not rely on constant oxygen for daily activities.
GroningenAges Any age - NCT06704451Recruiting
IL-33 and memory after major abdominal surgery
This study looks at whether a protein called IL-33 is linked to memory and thinking problems that can happen after major abdominal surgery. It may help doctors find patients at risk earlier.
Kunming, YunnanAges Any age - NCT06704555RecruitingPhase 2
Radiation plus drug combo for untreated bulky follicular lymphoma
This trial tests a combination of radiation, an immunotherapy drug (tislelizumab), and chemotherapy (RCHOP) for people with previously untreated bulky follicular lymphoma. It aims to see if giving radiation first followed by the drug combo can improve outcomes for larger tumors.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT06704581RecruitingPhase 3
Study of BGM0504 injection for weight loss
This study tests a new weekly injection (BGM0504) to help people with obesity or overweight lose weight. It may be an option if you have not had success with diet and exercise alone and meet certain health criteria.
Beijing, Beijing MunicipalityAges 18–65 - NCT06705023RecruitingPhase 2
Fat-derived cell therapy for heart failure
This study tests whether taking a small amount of your own belly fat (through liposuction), processing it, and injecting the cells back into your heart can improve heart function in people with chronic heart failure due to blocked arteries. The trial is for patients whose heart pumps weakly (ejection fraction of 40% or less) and who are already on standard medications.
AstanaAges 21–80 - NCT06705907Recruiting
Helping middle-schoolers with autism improve school and social skills
This study tests a program to help middle school students with autism who have trouble with organization, planning, and social skills. It aims to improve their academic and social functioning in school.
Cincinnati, OhioAges 10–15 - NCT06707012RecruitingPhase 4
Metformin plus antidepressants for depression in obesity
This trial tests whether adding metformin (a diabetes medicine) to usual antidepressant treatment can help improve depression in people who are overweight or obese. It is for adults age 18–44 who are newly diagnosed with depression and do not have diabetes.
Karachi, SindhAges 18–45 - NCT06707194RecruitingPhase 4
Penicillin plus etanercept for spondyloarthritis
This trial tests whether adding a common antibiotic (benzathine penicillin) to a standard biologic drug (etanercept) can better treat spondyloarthritis. It may help if you have active disease and are free of certain infections.
Hefei, AnhuiAges 18–59 - NCT06707220Recruiting
Türkiye heart failure registry
This trial is a heart failure registry that collects information from people with heart failure across Turkey. By joining, researchers can learn more about the condition and how to treat it better.
Ankara, AnkaraAges 18 years+ - NCT06707233RecruitingPhase 2
Y-90 radioembolization for large liver cancer (over 7 cm)
This trial tests a treatment called Y-90 radioembolization (SIRT) for people with liver cancer that is too large to be removed surgically. The treatment delivers tiny radioactive beads directly to the tumor through the liver's blood supply, which may shrink the tumor and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT07685860Recruiting
PET scan study for depression with MAO-A
This study uses a special PET scan to look at MAO-A, a brain chemical linked to depression. It may help doctors better understand and diagnose depression.
Hefei, AnhuiAges 18–90 - NCT04383262RecruitingPhase 2
Fosamprenavir for reflux-related throat inflammation
This Phase 2 study tests whether fosamprenavir can reduce inflammation and enzyme activity in the throat area for people with laryngopharyngeal reflux (LPR). If you still have LPR symptoms despite 3 months of twice-daily reflux medicine, this trial may offer another treatment approach.
Milwaukee, WisconsinAges 18–64 - NCT06342440Recruiting
Early detection of colon cancer and advanced polyps
This study aims to find colorectal cancer and advanced polyps (adenomas) earlier by looking at blood samples. Researchers hope a simple blood test might one day help detect colon cancer before it spreads.
Monrovia, CaliforniaAges 18 years+ - NCT06342401Recruiting
Early onset colorectal cancer detection study
This study aims to improve detection of colorectal cancer in people diagnosed before age 50. It compares samples from patients with cancer to those without to find new early detection methods.
Duarte, CaliforniaAges 18–50 - NCT07684053Recruiting
Digital screening for irregular heartbeat to prevent stroke
This study tests if using a digital device (like a smartwatch or phone) can help find an irregular heartbeat called atrial fibrillation. Finding it early may help prevent stroke, especially in people over 65.
Innsbruck, TyrolAges 65 years+ - NCT07685015Recruiting
Myo-Inositol for blood sugar control in gestational diabetes
This trial tests if a natural supplement called myo-inositol can help manage blood sugar and reduce stress on your body during pregnancy while you have gestational diabetes.
Vienna, State of ViennaAges 18–45 - NCT03756870Recruiting
Stent procedure vs best medical care for blocked heart arteries
This trial studies whether opening a completely blocked heart artery (a CTO) with a procedure and stent helps reduce areas of low blood flow in the heart, compared with the best medicines alone. It uses heart scans to find people likely to benefit and then checks results again at 6 months.
AmsterdamAges 18 years+ - NCT06342414Recruiting
Blood test to tell apart two types of liver cancer
This study uses a blood test (called a liquid biopsy) to help doctors tell the difference between two common types of liver cancer: hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). If you have been diagnosed with one of these cancers and have a blood sample taken before starting curative treatment, this study may help improve diagnosis and care.
Duarte, CaliforniaAges 18 years+ - NCT07688356RecruitingPhase 2
Belvarafenib for BRAF-altered brain tumors
This trial tests a drug called Belvarafenib for people with brain tumors that have a BRAF gene change (mutation). The drug targets this specific change to try to shrink or control the tumor. It is for patients whose brain tumor has come back or hasn't responded to other treatments.
SeoulAges 19 years+ - NCT04695600RecruitingPhase 2/Phase 3
Botox for swallowing problems after brain injury
This trial tests if Botox injections in the throat can help people who have trouble swallowing due to a brain condition like stroke. It aims to improve safety and ease of eating and drinking.
New Delhi, National Capital Territory of DelhiAges 14 years+ - NCT07685847Recruiting
Suppository for chronic prostatitis or pelvic pain relief
This trial tests a rectal suppository (Prospidol®) to see if it can relieve pain and other symptoms in men with long-term prostatitis or pelvic pain. It is for men who have not had treatment recently and have no signs of infection or other serious illnesses.
Avellino, AvellinoAges 18–60 - NCT06549426Recruiting
Treating seizure activity after cardiac arrest
This trial tests a treatment for seizure-like brain activity that can happen after a cardiac arrest. It aims to see if treating these seizures quickly can improve recovery for people who are in a coma.
BrusselsAges 18 years+ - NCT06490159Recruiting
Predicting nerve damage from paclitaxel for stomach cancer
This study looks at whether a common chemotherapy drug called paclitaxel (Taxol) causes nerve damage (peripheral neuropathy) in people with advanced stomach cancer. The goal is to find out who is most likely to get this side effect, so doctors can better protect patients during treatment.
Kurashiki, Okayama-kenAges 20 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,451 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.